tldrdaily.news logo
Tag

Maternal Vaccine

All articles tagged with #maternal vaccine

health2 years ago

CDC Advises Pfizer Maternal RSV Vaccine for Infant Protection Amid Tripledemic Threat

The Centers for Disease Control and Prevention's advisory panel has recommended Pfizer's maternal vaccine, Abrysvo, to protect infants from respiratory syncytial virus (RSV), the leading cause of hospitalization among babies in the U.S. The vaccine is to be administered to expectant mothers between 32 to 36 weeks into their pregnancy during September through January. The recommendation is pending approval from CDC Director Mandy Cohen. Pfizer's vaccine is the first RSV treatment to use maternal immunization, providing infants with protection against the virus from birth through the first six months of life. The panel's recommendation comes as RSV begins to spread at higher levels, and public health officials hope the vaccine will help combat the virus this fall and winter.

via CNBC|
#cdc#health#infants
health2 years ago

"RSV Vaccines: A New Tool for Parents to Fight Respiratory Syncytial Virus"

The CDC's vaccine advisory committee is considering recommending Pfizer's maternal RSV vaccine, which gained FDA approval in August, to provide additional protection against the virus for infants. If approved, it would be the second tool available to protect infants against RSV, which causes thousands of hospitalizations and deaths in children under 5 each year. The maternal vaccine may be easier to distribute as it can be administered during pregnancy, but some pregnant individuals may miss the window for vaccination. An alternative option is the monoclonal antibody, which is ideal for babies who cannot receive the maternal vaccine. The rollout of the monoclonal antibody may be more challenging due to billing processes. Some infants may be candidates for both shots. In other news, Rep. Morgan Griffith supports allowing Medicare to negotiate drug prices through a competitive bidding process, and the Senate HELP Committee has advanced a package to bolster primary care access. FDA Commissioner Robert Califf is on a global tour, meeting with health officials in India and Singapore. The Reagan-Udall Foundation plans to release a report on how the FDA can combat misinformation effectively, and Steve Tilton has been named the new head of federal advocacy for PhRMA.

via POLITICO|
#cdc#health#maternal-vaccine
health2 years ago

Experts warn of potential risks for pregnant women in Pfizer vaccine trials.

Experts have raised concerns that Pfizer's respiratory syncytial virus (RSV) vaccine given to mothers-to-be could increase the risk of premature births. While no safety concerns were alerted by Pfizer in its own phase three trial, experts have called for tougher scrutiny over the new maternal RSV vaccine. The vaccine aims to protect infants from severe illness caused by the virus and could be approved in the US and UK later this year. The FDA is expected to make a decision by August, and experts have suggested the data should be analyzed further while the FDA should carry out post-approval monitoring, if approved.

via Daily Mail|
#fda#health#maternal-vaccine
health2 years ago

Pfizer's RSV vaccine shows promising results in preventing severe infection in infants.

Pfizer's experimental RSV vaccine was 82% effective in preventing severe infections in infants when given to expecting mothers in the second half of their pregnancy, according to final trial data. The vaccine, currently under review by health regulators in the US and Europe, could become the first maternal vaccine available to prevent the disease in infants if approved by the FDA by August. The shot failed to meet a second main goal of reducing non-severe illness in infants.

via Reuters|
#fda-approval#health#infants